ABIVAX Société Anonyme (ABVX) Competitors $8.70 -0.16 (-1.81%) (As of 09:48 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends ABVX vs. WVE, KROS, CGON, AKRO, AMPH, MIRM, APGE, NAMS, HRMY, and IRONShould you be buying ABIVAX Société Anonyme stock or one of its competitors? The main competitors of ABIVAX Société Anonyme include Wave Life Sciences (WVE), Keros Therapeutics (KROS), CG Oncology (CGON), Akero Therapeutics (AKRO), Amphastar Pharmaceuticals (AMPH), Mirum Pharmaceuticals (MIRM), Apogee Therapeutics (APGE), NewAmsterdam Pharma (NAMS), Harmony Biosciences (HRMY), and Disc Medicine (IRON). These companies are all part of the "pharmaceutical products" industry. ABIVAX Société Anonyme vs. Wave Life Sciences Keros Therapeutics CG Oncology Akero Therapeutics Amphastar Pharmaceuticals Mirum Pharmaceuticals Apogee Therapeutics NewAmsterdam Pharma Harmony Biosciences Disc Medicine Wave Life Sciences (NASDAQ:WVE) and ABIVAX Société Anonyme (NASDAQ:ABVX) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation. Do institutionals and insiders hold more shares of WVE or ABVX? 89.7% of Wave Life Sciences shares are held by institutional investors. Comparatively, 47.9% of ABIVAX Société Anonyme shares are held by institutional investors. 29.1% of Wave Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts rate WVE or ABVX? Wave Life Sciences presently has a consensus target price of $22.22, indicating a potential upside of 55.07%. ABIVAX Société Anonyme has a consensus target price of $39.80, indicating a potential upside of 357.47%. Given ABIVAX Société Anonyme's higher possible upside, analysts clearly believe ABIVAX Société Anonyme is more favorable than Wave Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wave Life Sciences 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00ABIVAX Société Anonyme 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Does the MarketBeat Community favor WVE or ABVX? Wave Life Sciences received 357 more outperform votes than ABIVAX Société Anonyme when rated by MarketBeat users. However, 75.00% of users gave ABIVAX Société Anonyme an outperform vote while only 67.85% of users gave Wave Life Sciences an outperform vote. CompanyUnderperformOutperformWave Life SciencesOutperform Votes36367.85% Underperform Votes17232.15% ABIVAX Société AnonymeOutperform Votes675.00% Underperform Votes225.00% Which has higher valuation & earnings, WVE or ABVX? Wave Life Sciences has higher revenue and earnings than ABIVAX Société Anonyme. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWave Life Sciences$113.31M19.29-$57.51M-$1.11-12.91ABIVAX Société AnonymeN/AN/A-$159.90MN/AN/A Does the media favor WVE or ABVX? In the previous week, Wave Life Sciences had 31 more articles in the media than ABIVAX Société Anonyme. MarketBeat recorded 36 mentions for Wave Life Sciences and 5 mentions for ABIVAX Société Anonyme. Wave Life Sciences' average media sentiment score of 0.46 beat ABIVAX Société Anonyme's score of 0.42 indicating that Wave Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Wave Life Sciences 6 Very Positive mention(s) 1 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral ABIVAX Société Anonyme 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is WVE or ABVX more profitable? ABIVAX Société Anonyme has a net margin of 0.00% compared to Wave Life Sciences' net margin of -66.50%. ABIVAX Société Anonyme's return on equity of 0.00% beat Wave Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Wave Life Sciences-66.50% -280.57% -52.90% ABIVAX Société Anonyme N/A N/A N/A SummaryWave Life Sciences beats ABIVAX Société Anonyme on 10 of the 15 factors compared between the two stocks. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get ABIVAX Société Anonyme News Delivered to You Automatically Sign up to receive the latest news and ratings for ABVX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABVX vs. The Competition Export to ExcelMetricABIVAX Société AnonymePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$550.62M$6.48B$5.07B$8.80BDividend YieldN/A8.11%4.99%4.07%P/E RatioN/A4.9789.5613.60Price / SalesN/A371.451,224.8087.40Price / CashN/A52.5939.4536.27Price / Book2.5810.306.976.33Net Income-$159.90M$153.61M$119.04M$225.93M7 Day Performance-12.65%-1.73%-1.78%-0.96%1 Month Performance-17.14%-7.26%-3.59%1.06%1 Year Performance-18.16%31.10%31.64%26.59% ABIVAX Société Anonyme Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABVXABIVAX Société Anonyme3.0118 of 5 stars$8.70-1.8%$39.80+357.5%-19.6%$550.62MN/A0.0061WVEWave Life Sciences4.857 of 5 stars$14.33+0.5%$22.22+55.1%+174.2%$2.19B$113.31M-12.85240Analyst RevisionKROSKeros Therapeutics3.4913 of 5 stars$53.88-0.5%$88.89+65.0%+80.5%$2.18B$150,000.000.00100CGONCG Oncology3.1617 of 5 stars$32.11-0.4%$63.88+98.9%N/A$2.17B$200,000.000.0061Short Interest ↓Analyst RevisionPositive NewsAKROAkero Therapeutics4.0502 of 5 stars$30.43-0.7%$46.83+53.9%+83.8%$2.12BN/A0.0030Analyst ForecastInsider TradeAMPHAmphastar Pharmaceuticals4.7262 of 5 stars$44.070.0%$63.00+43.0%-22.1%$2.12B$644.40M14.701,761MIRMMirum Pharmaceuticals4.312 of 5 stars$43.95+0.6%$57.73+31.3%+36.1%$2.11B$186.37M0.00140Analyst RevisionAPGEApogee Therapeutics2.4639 of 5 stars$44.44-1.3%$78.50+76.6%+149.9%$2.00BN/A0.0091NAMSNewAmsterdam Pharma2.9488 of 5 stars$20.92+4.5%$33.80+61.6%+110.6%$1.93B$14.09M0.0057Insider TradeNews CoverageGap DownHRMYHarmony Biosciences4.7919 of 5 stars$33.01+0.7%$47.00+42.4%+18.1%$1.88B$582.02M15.54200IRONDisc Medicine3.1676 of 5 stars$62.99+0.7%$85.80+36.2%+22.4%$1.87BN/A0.0078Insider TradeAnalyst Revision Related Companies and Tools Related Companies WVE Competitors KROS Competitors CGON Competitors AKRO Competitors AMPH Competitors MIRM Competitors APGE Competitors NAMS Competitors HRMY Competitors IRON Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ABVX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABIVAX Société Anonyme Please log in to your account or sign up in order to add this asset to your watchlist. Share ABIVAX Société Anonyme With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABVX Stock Alerts